CCM
CVS icon

Callodine Capital Management’s CVS Health CVS Stock Holding History

Callodine Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-313,427
Closed -$23.6M – 56
2025
Q3 		$23.6M Sell
313,427
-204,573
-39% -$14M 2.07% 20
2025
Q2 		$35.7M Buy
518,000
+228,000
+79% +$15M 3.7% 10
2025
Q1 		$19.6M Buy
+290,000
New +$17.4M 3.27% 12

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Callodine Capital Management's CVS Position: Q4 2025 in Review

Callodine Capital Management sold out of CVS Health (CVS) in Q4 2025, closing a stake of 313,427 shares — an estimated $23.6M sold.

Callodine Capital Management first reported a position in CVS in Q1 2025 and held it in 3 quarters. The position peaked at $35.7M in Q2 2025. 1,945 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

  • Callodine Capital Management reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
  • Callodine Capital Management sold 313,427 CVS Health shares in Q4 2025, an estimated $23.6M.
  • Callodine Capital Management first reported a position in CVS Health in Q1 2025 and held it in 3 quarters.
  • Callodine Capital Management's CVS Health position peaked at $35.7M in Q2 2025.
  • 1,945 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Callodine Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.